A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Author:

Vichinsky Elliott1,Hoppe Carolyn C.1,Ataga Kenneth I.1,Ware Russell E.1,Nduba Videlis1,El-Beshlawy Amal1,Hassab Hoda1,Achebe Maureen M.1,Alkindi Salam1,Brown R. Clark1,Diuguid David L.1,Telfer Paul1,Tsitsikas Dimitris A.1,Elghandour Ashraf1,Gordeuk Victor R.1,Kanter Julie1,Abboud Miguel R.1,Lehrer-Graiwer Joshua1,Tonda Margaret1,Intondi Allison1,Tong Barbara1,Howard Jo1

Affiliation:

1. From the University of California, San Francisco (UCSF) Benioff Children’s Hospital Oakland, Oakland (E.V.), and Global Blood Therapeutics, South San Francisco (C.C.H., J.L.-G., M.T., A.I., B.T.) — both in California; the University of Tennessee Health Science Center at Memphis, Memphis (K.I.A.); Cincinnati Children’s Hospital and University of Cincinnati, Cincinnati (R.E.W.); Kenya Medical Research Institute, Kisumu, Kenya (V.N.); Cairo University, Cairo (A.E.-B.), and the Pediatric Department and...

Funder

Global Blood Therapeutics

Publisher

Massachusetts Medical Society

Subject

General Medicine

Cited by 450 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3